Disease Areas
Biomarker-based Dx for Alzheimer's Rise as Study Results Question Effectiveness in Different Races
Premium
A paper published last month found that blood-based biomarkers used in diagnostic tests for Alzheimer's may not work as well in African American patients.
DoMore Diagnostics Obtains CE Mark for AI Algorithm to Predict Colorectal Cancer Patient Outcomes
The algorithm, trained on and developed with around 100 million image tiles, analyzes high resolution scans from standard hematoxylin and eosin stained slides.
White House Launches Federally Supported Test-to-Treat Sites
The clinic will provide federal reimbursement for people who test positive for COVID-19 to be assessed by a medical provider and potentially receive antiviral treatment.
Local Coverage Determinations Roundup: Castle Bio, SkylineDx
Palmetto GBA released a final local coverage determination that covers tests from Castle Biosciences and SkylineDx.Â
CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood TestÂ
CorePath will develop and offer UK-based Cizzle's test in the US, with royalty agreements on all product and services offerings related to the test.Â